Skip to content

Clinical trials

Congenital, Hereditary, and Neonatal Diseases and Abnormalities trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital, Hereditary, and Neonatal Diseases and Abnormalities Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20028
20031
20047
20058
20065
20073
20083
20101
20111
20121
20161
20174
20183
20192
20202
20213
20225
20235
20242
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated39
Recruiting14
Unknown status5
Active, not recruiting4
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Healthcare of Atlanta49
Emory University12
Ain Shams University2
G. d'Annunzio University2
Taysha Gene Therapies, Inc.2
Agnieszka Czechowicz1
Ahmed Hamdy Rateb1
Arrowhead Pharmaceuticals1
Assiut University1
Biossil Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital, Hereditary, and Neonatal Diseases and Abnormalities107
Genetic Diseases, Inborn10
Heart Defects, Congenital9
Congenital Abnormalities4
Intellectual Disability4
Metabolic Diseases4
Metabolism, Inborn Errors4
Genetic Diseases, X-Linked3
Nervous System Diseases3
Anemia, Hypoplastic, Congenital2

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.